ProductLife Group adquiere Cilatus y amplía su experiencia en el desarrollo de productos complejos

Tras las adquisiciones de DS InPharmatics (DSI) en 2021 y Zwiers Regulatory Consultancy en 2022, ProductLife Group (PLG), un proveedor global de servicios normativos y de cumplimiento para la industria de las ciencias de la vida, fortalece aún más sus capacidades para respaldar las actividades de desarrollo de productos para sus clients, mediante la adquisición … Read more

XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm

HUDDINGE, Sweden, May 24, 2023 /PRNewswire/ — XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST. The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the … Read more

OMRON Healthcare celebra 50 años de historia del monitor de presión arterial

KIOTO, Japón, 24 de mayo de 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (en lo sucesivo, la Compañía) con sede en la ciudad de Muko, Prefectura de Kioto, Japón, se enorgullece en anunciar la celebración de su 50 aniversario en la producción de monitores de presión arterial este año. Desde la introducción de su primer … Read more

Iraqi Patient Successfully Undergoes Robotic-Assisted CABG Surgery at Manipal Hospital, Delhi

NEW DELHI, May 24, 2023 /PRNewswire/ — Doctors at Manipal Hospital, Delhi recently performed a groundbreaking robotic-assisted Coronary Artery Bypass Grafting (CABG) surgery on a 44-year-old male patient from Iraq. The patient came to the hospital with a complaint of chest pain and upon further diagnosis, it was found that the patient was suffering from … Read more

XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm

HUDDINGE, Sweden, May 24, 2023 /PRNewswire/ — XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST. The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the … Read more

Washington, DC, Park System Ranked Nation’s Best in Trust for Public Land’s Annual ParkScore® Index; Saint Paul Places Second, Minneapolis Third, Irvine Surges to Fourth

New Research: Cities with Highest ParkScore Rankings Are Healthier Places to Live,with More Physical Activity and Better Mental Health SAN FRANCISCO, May 24, 2023 /PRNewswire/ — Trust for Public Land announced today that Washington, DC, was rated the nation’s best big-city park system by the 2023 ParkScore® index. Saint Paul, Minnesota, placed second, Minneapolis climbed to third, … Read more

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Brixadi is the first treatment for opioid use disorder in the US with both weekly and monthly dosing Three million people in the US diagnosed with opioid use disorder LUND, Sweden, May 24, 2023 /PRNewswire/ — Camurus (NASDAQ STO: CAMX) today announces that the US Food and Drug Administration (FDA) has approved Brixadi™ (buprenorphine) extended release … Read more

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema

AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness (CST) improvements of -110 microns from baseline across … Read more

Holter ECG Markets by Product (Wired Holter ECG, Wireless Holter ECG, Software), Lead Type (Patch Type 1-Lead, 3-Lead, 6-Lead, 12-Lead)

DUBLIN, May 23, 2023 /PRNewswire/ — The “Holter ECG Market” report has been added to  ResearchAndMarkets.com’s offering. The global Holter ECG market is projected to reach USD 558 million by 2027 from USD 416 million in 2022, at a CAGR of 6.1% during the forecast period. The aging population, rising cardiovascular disease (CVD) prevalence, awareness … Read more

Karyopharm to Present New Selinexor Data at the 2023 American Society of Clinical Oncology and European Hematology Association Annual Meetings

NEWTON, Mass., May 23, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected to be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 2-6 in Chicago, Illinois and the … Read more